A major acquisition is underway in the Twin Cities medical technology sector. 3 billion. The sale comes after Bio-Techne faced pressure from activist groups to sell.

Further details about the acquisition and its implications are available from the Star Tribune. For those seeking more information about the deal and its potential impact on the local medtech industry, additional reporting can be found in the Star Tribune's coverage of the acquisition.